Most bought healthcare stocks in Q3 2018
See which Healthcare stocks institutional investors increased the most in Q3 2018, measured as net growth in reported share positions from Q2 2018 into Q3 2018. Notable additions at the top of this list include BAUSCH HEALTH COS INC (BHC), CVS HEALTH CORP (CVS), DENTSPLY SIRONA INC (XRAY), TEVA PHARMACEUTICAL-SP ADR (TEVA). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 26,521,342 | $680.80M | 5 | 0 | 0 | 0 | 5 |
| CVS | CVS HEALTH CORP | 9,253,623 | $1.15B | 1 | 0 | 6 | 1 | 8 |
| XRAY | DENTSPLY SIRONA INC | 4,897,084 | $146.08M | 1 | 2 | 2 | 1 | 6 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 3,657,365 | -$99.65M | 0 | 2 | 2 | 0 | 6 |
| BKD | BROOKDALE SENIOR LIVING INC | 3,299,418 | $34.56M | 0 | 1 | 0 | 0 | 1 |
| MCK | MCKESSON CORP | 3,229,549 | $422.09M | 1 | 4 | 1 | 1 | 6 |
| INVA | INNOVIVA INC | 2,682,147 | $39.44M | 0 | 2 | 0 | 0 | 2 |
| ELAN | ELANCO ANIMAL HEALTH INC | 2,664,173 | $92.95M | 2 | 0 | 0 | 0 | 2 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 2,576,602 | $85.42M | 0 | 2 | 0 | 0 | 2 |
| DHR | DANAHER CORP | 2,229,315 | $402.59M | 0 | 3 | 3 | 0 | 10 |
| AMRX | AMNEAL PHARMACEUTICALS INC | 1,918,275 | $42.57M | 2 | 0 | 0 | 0 | 2 |
| CAH | CARDINAL HEALTH INC | 1,834,172 | $145.79M | 1 | 0 | 4 | 0 | 6 |
| MOH | MOLINA HEALTHCARE INC | 1,639,026 | $385.45M | 0 | 1 | 0 | 1 | 1 |
| EXAS | EXACT SCIENCES CORP | 1,543,848 | $121.84M | 2 | 0 | 0 | 0 | 2 |
| ZTS | ZOETIS INC | 1,543,336 | $229.02M | 0 | 2 | 2 | 0 | 5 |
| MD | PEDIATRIX MEDICAL GROUP INC | 1,531,522 | $79.23M | 1 | 1 | 0 | 0 | 2 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 1,465,192 | $19.68M | 0 | 1 | 0 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | 1,275,334 | $61.10M | 1 | 0 | 1 | 1 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,240,206 | $41.18M | 0 | 1 | 0 | 0 | 1 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,238,200 | $323.49M | 0 | 1 | 0 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | 1,144,784 | $636.37M | 1 | 3 | 3 | 0 | 9 |
| EHC | ENCOMPASS HEALTH CORP | 1,085,120 | $93.29M | 0 | 1 | 1 | 0 | 2 |
| EXEL | EXELIXIS INC | 945,900 | $2.79M | 0 | 1 | 0 | 0 | 1 |
| COR | CENCORA INC | 944,302 | $134.77M | 0 | 2 | 0 | 0 | 2 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 943,160 | $103.20M | 0 | 2 | 1 | 0 | 3 |
| NTRA | NATERA INC | 942,471 | $31.16M | 0 | 1 | 0 | 0 | 1 |
| HAE | HAEMONETICS CORP/MASS | 937,000 | $162.01M | 0 | 1 | 0 | 0 | 1 |
| EDIT | EDITAS MEDICINE INC | 912,382 | $16.55M | 1 | 1 | 0 | 0 | 3 |
| CERS | CERUS CORP | 869,761 | $9.35M | 1 | 1 | 0 | 0 | 2 |
| ARDX | ARDELYX INC | 789,200 | $3.16M | 0 | 1 | 0 | 0 | 1 |
| RDY | DR. REDDY'S LABORATORIES-ADR | 766,900 | $26.67M | 0 | 1 | 0 | 0 | 2 |
| MEDP | MEDPACE HOLDINGS INC | 675,200 | $43.19M | 0 | 1 | 0 | 0 | 1 |
| OFIX | ORTHOFIX MEDICAL INC | 661,100 | $38.22M | 1 | 0 | 0 | 0 | 1 |
| PFE | PFIZER INC | 660,398 | $184.19M | 0 | 2 | 10 | 0 | 12 |
| MCRB | SERES THERAPEUTICS INC | 653,115 | $1.88M | 0 | 1 | 1 | 0 | 2 |
| ARAY | ACCURAY INC | 651,723 | $602.00K | 0 | 1 | 0 | 0 | 1 |
| VCYT | VERACYTE INC | 607,745 | $8.64M | 0 | 2 | 0 | 0 | 2 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 603,322 | $118.82M | 1 | 1 | 1 | 0 | 3 |
| RMD | RESMED INC | 566,577 | $68.59M | 0 | 1 | 0 | 0 | 1 |
| CTMX | CYTOMX THERAPEUTICS INC | 559,300 | $783.00K | 0 | 1 | 0 | 0 | 1 |
| SIGA | SIGA TECHNOLOGIES INC | 527,886 | $3.71M | 0 | 1 | 0 | 0 | 1 |
| STAA | STAAR SURGICAL CO | 513,200 | $37.67M | 0 | 1 | 0 | 0 | 1 |
| PDCO | PATTERSON COS INC | 501,841 | $15.43M | 0 | 1 | 1 | 0 | 2 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 485,000 | $5.08M | 0 | 1 | 0 | 0 | 1 |
| ANIK | ANIKA THERAPEUTICS INC | 454,952 | $17.67M | 1 | 1 | 0 | 0 | 2 |
| DXCM | DEXCOM INC | 422,116 | $71.47M | 0 | 1 | 0 | 0 | 1 |
| UTHR | UNITED THERAPEUTICS CORP | 410,200 | $76.26M | 0 | 1 | 0 | 0 | 1 |
| VNDA | VANDA PHARMACEUTICALS INC | 408,600 | $19.38M | 0 | 1 | 0 | 0 | 1 |
| BLFS | BIOLIFE SOLUTIONS INC | 400,100 | $7.34M | 0 | 1 | 0 | 0 | 1 |
| LGND | LIGAND PHARMACEUTICALS | 389,825 | $146.84M | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q3 2018
What are the most bought Healthcare stocks in Q3 2018?
The most bought healthcare stocks in Q3 2018 are those with the largest increase in reported share counts across institutional investors compared to Q2 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2018?
Among filers in this sector, net additions were largest in companies such as BAUSCH HEALTH COS INC (BHC), CVS HEALTH CORP (CVS), DENTSPLY SIRONA INC (XRAY), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.